IDO1 plays a crucial role in regulating immune responses and inflammation, potentially contributing to cognitive deterioration in PD patients [53], whereas MICB modulates natural killer and T cell activity, suggesting a complex immune regulatory mechanism underlying cognitive impairments [54]. Here, IDO1 is linked to Parkinson disease.